LGALS1 and COVID-19: Examination of ROC curve demonstrates that Gal-1 can be a potential marker for stage II (sensitivity 89.5%, specificity 23.4%; cut off: 3959 pg/ml) and stage III detection (sensitivity 72.2%, specificity 25.9%; cut off: 9359 pg/ml) in COVID-19 patients.